Literature DB >> 23670112

Improving adherence to medication in stroke survivors: a pilot randomised controlled trial.

Ronan E O'Carroll1, Julie A Chambers, Martin Dennis, Cathie Sudlow, Marie Johnston.   

Abstract

BACKGROUND: Adherence to preventive medication is often poor, and current interventions have had limited success.
PURPOSE: This study was conducted to pilot a randomised controlled trial aimed at increasing adherence to preventive medication in stroke survivors using a brief, personalised intervention.
METHODS: Sixty-two stroke survivors were randomly allocated to either a two-session intervention aimed at increasing adherence via (a) introducing a plan linked to environmental cues (implementation intentions) to help establish a better medication-taking routine (habit) and (b) eliciting and modifying any mistaken patient beliefs regarding medication/stroke or a control group. Primary outcome was adherence to antihypertensive medication measured objectively over 3 months using an electronic pill bottle.
RESULTS: Fifty-eight people used the pill bottle and were analysed as allocated; 54 completed treatment. The intervention resulted in 10 % more doses taken on schedule (intervention, 97 %; control, 87 %; 95 % CI for difference (0.2, 16.2); p = 0.048).
CONCLUSIONS: A simple, brief intervention increased medication adherence in stroke survivors, over and above any effect of increased patient contact or mere measurement.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23670112     DOI: 10.1007/s12160-013-9515-5

Source DB:  PubMed          Journal:  Ann Behav Med        ISSN: 0883-6612


  40 in total

1.  Adherence to medication in stroke survivors dependent on caregivers.

Authors:  Anna De Simoni; Jonathan Mant; Stephen Sutton
Journal:  Br J Gen Pract       Date:  2015-11       Impact factor: 5.386

2.  Habit Strength and Adherence to Oral Contraceptives: the Role of Time- and Place-Based Cues.

Authors:  Jane Murphy; Neidin Eustace; Kiran M Sarma; Gerard J Molloy
Journal:  Int J Behav Med       Date:  2018-08

3.  Stroke patients' support: evaluation of knowledge, practices and training needs of French community pharmacists.

Authors:  Sophie Khettar; Marie Viprey; Julie Haesebaert; Sophie Jacquin-Courtois; Jacques Luauté; Laura Mechtouff; Laurent Derex; Gilles Rode; Claude Dussart; Audrey Janoly-Dumenil
Journal:  Int J Clin Pharm       Date:  2021-01-02

Review 4.  Necessity and concerns beliefs and HIV medication adherence: a systematic review.

Authors:  Luke D Mitzel; Peter A Vanable
Journal:  J Behav Med       Date:  2019-08-08

5.  Development and validation of CF-Medication Beliefs Questionnaire: A mixed-methods approach.

Authors:  Michelle N Eakin; Shang-En Chung; Jessica Hoehn; Belinda Borrelli; Devin Rand-Giovannetti; Kristin A Riekert
Journal:  J Cyst Fibros       Date:  2017-05-23       Impact factor: 5.482

6.  Improving Prospective Memory in Persons With Parkinson Disease: A Randomized Controlled Trial.

Authors:  Erin R Foster; Mark A McDaniel; Peter G Rendell
Journal:  Neurorehabil Neural Repair       Date:  2017-02-08       Impact factor: 3.919

Review 7.  A Systematic Review and Meta-Analysis on Self-Management for Improving Risk Factor Control in Stroke Patients.

Authors:  Brodie M Sakakibara; Amy J Kim; Janice J Eng
Journal:  Int J Behav Med       Date:  2017-02

8.  Use of automated medication adherence monitoring in bipolar disorder research: pitfalls, pragmatics, and possibilities.

Authors:  Jennifer B Levin; Johnny Sams; Curtis Tatsuoka; Kristin A Cassidy; Martha Sajatovic
Journal:  Ther Adv Psychopharmacol       Date:  2015-04

9.  The psychosocial context impacts medication adherence after acute coronary syndrome.

Authors:  Ian M Kronish; Nina Rieckmann; Matthew M Burg; Carmela Alcántara; Karina W Davidson
Journal:  Ann Behav Med       Date:  2014-04

10.  Encoding strategy training and self-reported everyday prospective memory in people with Parkinson disease: a randomized-controlled trial.

Authors:  Susan Goedeken; Cathryne Potempa; Eliza M Prager; Erin R Foster
Journal:  Clin Neuropsychol       Date:  2017-10-13       Impact factor: 3.535

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.